Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
"Beijing Smart" most plausibly refers to Beijing Smart Dragon Biotechnology, a small private Chinese company registered as 北京聪明龙生物科技有限公司. Available public records indicate it is an active company in Beijing that changed its name from a trading company to a biotechnology company in 2019, but the disclosed business scope appears centered on health-related food products, special medical purpose foods, infant formula, and related technology services rather than a traditional drug-development biotech pipeline. I did not find reliable evidence of clinical-stage therapeutics, named drug candidates, or major pharma partnerships. Because the requested name is ambiguous and the strongest exact-name matches are sparse, this should be treated as a best-effort identification rather than a confirmed exact match. The company appears to operate more like a small health-products/biotech-branded commercial company than a venture-backed innovative therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Smart.